U.S. Semiconductors Stock News

NasdaqGS:NXT
NasdaqGS:NXTElectrical

Nextpower Prevalon Deal Extends Reach Into Storage Software And AI Data Centers

Nextpower (NasdaqGS:NXT) has entered a definitive agreement to acquire Prevalon Energy. The deal expands Nextpower beyond solar hardware into battery energy storage systems and intelligent energy management software. The acquisition targets critical infrastructure customers, including AI data centers and utilities. Nextpower, trading at $156.51, has seen sharp share price moves recently, with the stock up 19.9% over the past week and 37.0% over the past month. Returns of 68.7% year to date...
NYSE:NUE
NYSE:NUEMetals and Mining

Is It Too Late To Consider Nucor (NUE) After Its 132% One-Year Rally?

If you are wondering whether Nucor stock still offers value at current levels, the key is understanding what the recent share price is actually pricing in. The stock last closed at US$250.00, with returns of 7.8% over 7 days, 12.4% over 30 days, 47.6% year to date and 132.1% over 1 year. This naturally raises questions about how much upside or downside may be left. Recent coverage of Nucor has focused on its position within the broader materials sector and how investor sentiment around steel...
NYSE:STT
NYSE:STTCapital Markets

State Street ETF Closure Tests Confidence In Broader STT Valuation Story

State Street plans to close and liquidate the State Street DoubleLine Emerging Markets Fixed Income ETF (EMTL). Final trading in EMTL is expected to occur in July 2026, after which the fund will be liquidated. The decision affects existing EMTL shareholders and adds a fresh data point to how State Street manages its ETF lineup. For investors watching State Street (NYSE:STT), this move comes as the stock trades at $155.64, with a reported return of 20.6% year to date and 66.2% over the past...
NYSE:LII
NYSE:LIIBuilding

A Look At Lennox International (LII) Valuation After Earnings Beat And Dividend Increase

Board moves and dividend change put Lennox International (LII) in focus Lennox International (LII) is back on investors’ radar after a quarterly report that beat revenue expectations, a higher quarterly dividend, and a board reshuffle that reduced director seats from nine to eight. See our latest analysis for Lennox International. Lennox International’s recent revenue beat, dividend increase and board changes come after a mixed period for the stock. The share price is down about 12% over...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

EPlus (PLUS) Q4 Revenue Beat Tests Bullish Valuation Narratives

ePlus (PLUS) closed out FY 2026 with fourth quarter revenue of US$581.6 million and basic EPS of US$0.97, setting the stage for investors to reassess how the business is trending into the new year. The company has seen quarterly revenue move from US$498.1 million in Q4 FY 2025 to US$581.6 million in Q4 FY 2026, while basic EPS in those periods came in at US$0.96 and US$0.97 respectively. Over the last 12 months, net income excluding extra items totaled US$124.1 million on revenue of US$2.4...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

Is It Too Late To Consider NetApp (NTAP) After Its Recent 79% Share Price Surge

Wondering if NetApp at US$174.29 is still offering value after a strong run, or if expectations have already been priced in? This article focuses squarely on what the current share price implies. The stock has posted returns of 25.1% over the past week, 60.4% over the past month, 63.7% year to date and 79.2% over the last year, with longer term figures of 161.3% over three years and 142.6% over five years that many investors will want to put into context. Recent market conversation around...
NYSE:BNY
NYSE:BNYCapital Markets

Is It Too Late To Consider Bank of New York Mellon Corporation (BNY) After 60% One-Year Rally?

Wondering if BNY is still worth a closer look after its run, or if most of the value is already reflected in the share price? This article breaks down what the current price might be implying. Bank of New York Mellon Corporation's stock recently closed at US$139.43, with returns of 0.2% over 7 days, 5.4% over 30 days, 19.1% year to date and 60.3% over the last year. The 3 year return is around 3x and the 5 year return is just over 2x. Recent headlines around BNY have focused on its role as a...
NYSE:UVV
NYSE:UVVTobacco

Universal (UVV) Margin Compression And One Off Loss Test Bullish Growth Narratives

Universal (NYSE:UVV) FY 2026 Earnings Snapshot Universal (NYSE:UVV) closed out FY 2026 with Q4 revenue of US$715.2 million and a reported loss per share of US$1.73, as investors weighed these headline figures against full year trends. Over the past six quarters, revenue has moved between US$593.8 million and US$937.2 million per quarter, while quarterly EPS ranged from US$0.34 to US$2.39 before this latest loss. This gives you a wide band of outcomes to factor into your view on the stock...
NYSE:HII
NYSE:HIIAerospace & Defense

Is It Too Late To Consider Huntington Ingalls Industries (HII) After The Recent Pullback?

Wondering whether Huntington Ingalls Industries, at around US$308 a share, still offers value or if most of the opportunity has already been priced in. The stock is down 3.9% over the past week and 14.9% over the past month, yet it still shows a 40.5% return over 1 year and 58.2% over 3 years, which can change how you think about both risk and opportunity. Recent coverage has focused on Huntington Ingalls Industries as a key US defense contractor, with attention on its role in major long...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta (OKTA) Margin Expansion Reinforces Bullish Profitability Narratives In Q1 2027

Q1 2027 earnings set the stage Okta (OKTA) has just opened Q1 2027 with revenue of US$765 million and basic EPS of US$0.42, putting fresh numbers behind a year in which trailing EPS reached US$1.40 on US$3.0 billion of revenue and net income of US$247 million. Over the past six reported quarters, revenue has moved from US$682 million in Q4 2025 to US$765 million in Q1 2027, while quarterly basic EPS has ranged between US$0.13 and US$0.42. This gives investors a clearer picture of how profit...
NYSE:EMN
NYSE:EMNChemicals

Is Eastman Chemical (EMN) Offering Value After Recent Share Price Rebound?

Wondering if Eastman Chemical at around US$75.87 is offering real value or just fair pricing? This article walks through what the numbers say about the stock. The share price return sits at 2.4% over the past week, 7.7% over the past month, 17.9% year to date and 1.6% over the past year, against a longer-term picture that includes a 3.5% return over three years and a decline of 29.7% over five years. Recent coverage has focused on Eastman Chemical's role as a diversified materials producer,...
NYSE:COUR
NYSE:COURConsumer Services

Is Coursera (COUR) Offering Value After Recent Share Price Weakness And Growth Partnership Focus

Wondering whether Coursera at US$5.39 is starting to look like value, or if the stock still carries more risk than reward. The share price has inched up about 1.3% over the last week, but is still down about 11.8% over the past month, 23.9% year to date and 39.1% over the last year, which may catch the eye of investors looking for a reset opportunity. Recent headlines have focused on Coursera's position as a major online learning platform and its role in digital upskilling partnerships. This...
NYSE:LOB
NYSE:LOBBanks

Is It Time To Reconsider Live Oak Bancshares (LOB) After Its 39% One Year Run?

Wondering whether Live Oak Bancshares at around US$38.03 is offering fair value right now, or if the recent price puts it out of your comfort zone? The stock has returned 2.0% over the past week, 0.6% over the last month, 9.6% year to date and 39.0% over the past year, while the 5 year return shows a decline of 32.9%. These moves have come as Live Oak Bancshares continues to attract attention in the US regional banking space, with investors watching how its lending focus and digital platform...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics' BRIUMVI Data Supports Simplified Regimen And Valuation Upside

TG Therapeutics reported positive Phase 3 ENHANCE results for BRIUMVI, confirming a single 600 mg Day 1 infusion is bioequivalent to the current two-infusion initiation regimen for multiple sclerosis. The simplified regimen is intended to reduce treatment burden for patients and infusion centers while maintaining safety and efficacy outcomes seen in the trial. The company plans to submit these data to regulators, aiming to update the BRIUMVI label pending review and approval. For investors...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Cadence Samsung 2nm Alliance Deepens Role In Next Generation AI Design

Cadence Design Systems (NasdaqGS:CDNS) and Samsung Foundry agreed a multi-year expansion of their collaboration around second-generation 2nm process technology. The deal covers a broad Memory and Interface IP portfolio and certification of Cadence's AI focused design and analysis flows across Samsung's next generation 2nm and 3D IC platforms. The partnership targets next generation AI infrastructure and hardware, aiming to provide a more complete platform for advanced chip design. For...
NasdaqGS:TRMK
NasdaqGS:TRMKBanks

Trustmark Retail Banking Leadership Change And What It Means For Investors

Trustmark (NasdaqGS:TRMK) announced the retirement of Wayne A. Stevens as President of Retail Banking. Stevens concludes a career of more than four decades with the company, including service as an executive officer since 2009. The change affects leadership of one of Trustmark’s core business areas, retail banking. For a regional financial institution like Trustmark, retail banking sits at the heart of its business model, connecting deposit customers, consumer lending and local branch...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Intuitive Surgical Ties Da Vinci 5 Upgrades To Global Growth Push

Intuitive Surgical (NasdaqGS:ISRG) is rolling out more than 100 upgrades to its da Vinci 5 robotic surgery platform, including extended-use Force Feedback instruments aimed at reducing per procedure costs. The company has also promoted Taylor Patton to Chief Commercial and Marketing Officer, positioning her to lead global commercialization efforts for da Vinci 5 and other platforms. For anyone following surgical robotics, Intuitive Surgical sits at the center of one of the most closely...
NasdaqGS:ARXS
NasdaqGS:ARXSAerospace & Defense

Arxis IPO, Record Quarter And Micro-Tronics Deal Shape Growth Path

Arxis, ticker NasdaqGS:ARXS, reported record first quarter financial results. The company completed its IPO and used proceeds to strengthen its balance sheet and fund future growth. Arxis acquired Micro-Tronics, adding aerospace and defense component capabilities. Arxis operates in markets tied to aerospace and defense components, areas that often rely on precision engineering, long product cycles, and high qualification standards. The record first quarter performance, combined with the...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Is It Too Late To Consider Guardant Health (GH) After A 246% One Year Surge?

If you are wondering whether Guardant Health at around US$133 is starting to look stretched or still offers value, this article walks through the key signals that may matter to you as a shareholder or potential buyer. The stock has logged returns of 12.9% over the past week, 60.3% over the past month, 30.9% year to date and 245.6% over the past year. This puts recent pricing firmly in focus for any valuation check. Recent coverage has highlighted Guardant Health as a high growth healthcare...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave Joins S&P SmallCap 600 As Growth And Valuation Thesis Evolve

Dave Inc. (NasdaqGM:DAVE) is set to join the S&P SmallCap 600 Index, reflecting the company’s progress and growing presence in public markets. The index change is scheduled to take effect soon, positioning Dave alongside a broader group of small cap companies followed by institutional investors. Dave operates as a financial services platform, focusing on tools that help consumers manage cash flow and avoid common banking fees. Inclusion in the S&P SmallCap 600 Index brings the company into...
NYSE:RCL
NYSE:RCLHospitality

Is It Too Late To Consider Royal Caribbean Cruises (RCL) After Its Strong Share Price Run?

Wondering whether Royal Caribbean Cruises at around US$281 per share still offers value, or if most of the easy gains are already behind it. The stock has returned 8.1% over the past week and 9.9% over the last month, while year to date it is down 0.7% and the 1 year return sits at 12.2%, with a very large 3 year gain and a 203.8% return over 5 years. Recent headlines around Royal Caribbean Cruises have often focused on its share price strength and ongoing investor interest in the cruise...
NYSE:PLD
NYSE:PLDIndustrial REITs

Does Prologis (PLD) Still Offer Value After A 38% One-Year Share Price Gain?

If you are wondering whether Prologis stock still offers value at current levels, it helps to step back and separate price excitement from underlying worth. The stock last closed at US$145.64, with returns of 0.7% over 7 days, 2.9% over 30 days, 12.9% year to date and 38.0% over 1 year, which naturally raises questions about what is already reflected in the share price. Recent headlines around Prologis have focused on its role as a major industrial real estate player, including coverage of...
NYSE:AN
NYSE:ANSpecialty Retail

Assessing AutoNation (AN) Valuation As Shares Trade Below Analyst Targets

Why AutoNation Stock Is On Investors’ Radar AutoNation (AN) stock is drawing attention after recent trading swings, with the share price at about $193.74 and mixed short term returns that include gains over the past week but softness over the past month. See our latest analysis for AutoNation. Recent trading has been choppy, with the share price down 6.17% year to date, while the 1 year total shareholder return is 6.10% and the 5 year total shareholder return is 91.86%. This suggests...
NYSE:XXI
NYSE:XXICapital Markets

Assessing Twenty One Capital (XXI) Valuation After A Steep Share Price Fall And Recent Rebound

Why Twenty One Capital is on investors’ radar Twenty One Capital (XXI) has drawn attention after a challenging year for the stock, with the share price down 82.6% over the past 12 months despite a market value of about US$2.5b. See our latest analysis for Twenty One Capital. At the current share price of US$7.33, the stock has seen a 90 day share price return of 27.7%, which only partially offsets the 1 year total shareholder return decline of 82.6%. This suggests that recent momentum is...